Subscribe Register Login
Friday, April 20, 2018, 2:15 a.m.

This exclusive story is reserved for our subscribers.

Support independent journalism by subscribing to the Arkansas Democrat-Gazette.

Subscribe now to continue reading.

Corporate fine appeal hits court

The $1. 2 billion fine against Johnson & Johnson and a subsidiary for Medicaid fraud was not excessive, because the company continuously put patients in danger by improperly exposing them to the side effects of the antipsychotic drug Risperdal, an attorney for the state told the Arkansas Supreme Court on Thursday.

Click here to login or subscribe below.

Home Delivery
& Online
Online Only
Get Started Get Started
Breaking News
Newspaper Content Online
Smartphone Access
Tablet App (iPad) Access
Home Delivery
Sunday Comics, Ad Inserts, Coupons